Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Researchers have used large-scale virtual compound libraries, in silico screening and computer simulations to identify small ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Researchers at Karolinska Institutet have identified small molecules capable of influencing a hard-to-target receptor family ...

Results showed CNS target engagement with reduction in GCase substrate glucosylsphingosine (GluSph) in cerebrospinal fluid (CSF), a prespecified ...

Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.

Neurocrine Biosciences, Inc. today announced a new chapter in its research and development strategy, designed to fuel the Company's next era for growth and deliver long-term value. Neurocrine ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...

Detailed price information for Neuphoria Therapeutics Inc (NEUP-Q) from The Globe and Mail including charting and trades.

Many a person, with a variety of medical concerns, has looked into or tried acupuncture. As a practitioner myself, and with a ...

RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal ...